According to the MHRA Summary of Product Characteristics, additional contraceptive precautions (such as barrier methods or non-oral contraception) are recommended for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase
The LEADER trial (cardiovascular outcomes study in type 2 diabetes) showed that liraglutide, a similar GLP-1 agonist, reduced major adverse cardiac events by 13%
AAD Clinical Guidelines , 2024.
Postoperative recovery : Do not resume semaglutide if you are experiencing ongoing postoperative nausea, vomiting, inability to maintain adequate oral intake, or any surgical complications
If weight loss stalls, consult with your provider about adjusting the dosage to find what works best for you
Who Can Benefit from Glutathione Injections